PanCareSurPass Project HL7 FHIR Implementation Guide
0.1.0 - trial-use
150
PanCareSurPass Project HL7 FHIR Implementation Guide
0.1.0 - trial-use
150
This page is part of the PanCareSurPass Project HL7 FHIR Implementation Guide (v0.1.0: QA Preview) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions 
| Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskcondition-eu-pcsp | Version: 0.1.0 | |||
| Active as of 2023-01-26 | Computable Name: RiskCondition | |||
Condition at risk proposed by the PCSP algorithm
References
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp
This value set contains 47 concepts
Expansion based on PCSP Conditions at risk v0.1.0 (CodeSystem)
| Code | System | Display | Definition |
| 1 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent thyroid cancer | Subsequent thyroid cancer |
| 2 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent breast cancer | Subsequent breast cancer |
| 3 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) |
| 4 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Impaired fertility Impaired spermatogenesis | Impaired fertility Impaired spermatogenesis |
| 5 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Testosterone deficiency | Testosterone deficiency |
| 6 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Physical sexual dysfunction | Physical sexual dysfunction |
| 7 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Premature ovarian insufficiency | Premature ovarian insufficiency |
| 8 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Ear problems | Ear problems |
| 9 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Impaired glucose metabolism and diabetes melitus | Impaired glucose metabolism and diabetes melitus |
| 10 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Dyslipidemia | Dyslipidemia |
| 11 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Overweight and obesity | Overweight and obesity |
| 12 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Hypertension | Hypertension |
| 13 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Reduced bone mineral density | Reduced bone mineral density |
| 14 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Osteonecrosis | Osteonecrosis |
| 15 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) |
| 16 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) |
| 17 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Central precocious puberty (CPP) For girls with age below 8 years | Central precocious puberty (CPP) For girls with age below 8 years |
| 18 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Central precocious puberty (CPP) For boys with age below 9 yearss | Central precocious puberty (CPP) For boys with age below 9 yearss |
| 19 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Thyroid function problems | Thyroid function problems |
| 20 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cerebrovascular problem | Cerebrovascular problem |
| 21 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Neurocognitive problems | Neurocognitive problems |
| 22 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Peripheral neuropathy | Peripheral neuropathy |
| 23 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cataract | Cataract |
| 24 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Eye problems | Eye problems |
| 25 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Craniofacial growth problems | Craniofacial growth problems |
| 26 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Spine scoliosis and kyphosis | Spine scoliosis and kyphosis |
| 27 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Lower urinary tract problems | Lower urinary tract problems |
| 28 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Obstetric problems | Obstetric problems |
| 29 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Dental and oral problems | Dental and oral problems |
| 30 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Gastro-intestinal problems | Gastro-intestinal problems |
| 31 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Arrhythmia | Arrhythmia |
| 32 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Pulmonary problems | Pulmonary problems |
| 33 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Renal problems (Glomerular dysfunction - Tubular dysfunction) | Renal problems (Glomerular dysfunction - Tubular dysfunction) |
| 34 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Liver problems | Liver problems |
| 35 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Iron overload | Iron overload |
| 36 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Spleen problems | Spleen problems |
| 37 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Tumor predisposition | Tumor predisposition |
| 38 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent melanoma and non-melanoma skin cancer | Subsequent melanoma and non-melanoma skin cancer |
| 39 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent colorectal cancer | Subsequent colorectal cancer |
| 40 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent Oral Cancer | Subsequent Oral Cancer |
| 41 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent acute myeloid leukaemia or myelodysplasia | Subsequent acute myeloid leukaemia or myelodysplasia |
| 42 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent bladder cancer | Subsequent bladder cancer |
| 43 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent Bone Cancer | Subsequent Bone Cancer |
| 44 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent lung cancer | Subsequent lung cancer |
| 45 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent CNS neoplasms | Subsequent CNS neoplasms |
| 46 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) |
| 47 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Renal problems (Tubular dysfunction) | Renal problems (Tubular dysfunction) |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2021+ PanCareSurPass Project. Package hl7.eu.fhir.pcsp#0.1.0 based on FHIR 4.0.1. Generated 2023-01-26
Links: Table of Contents |
QA Report
The PanCareSurPass Research and Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 899999.
